Tianjin Pharmaceutical Group Co., Ltd.
Tianjin Pharmaceutical Group Co., Ltd., commonly referred to as Tianjin Pharma, is a leading player in the pharmaceutical industry, headquartered in Tianjin, China. Established in 1994, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including generic drugs, active pharmaceutical ingredients (APIs), and biopharmaceuticals. With a strong presence in both domestic and international markets, Tianjin Pharma is renowned for its commitment to quality and innovation. The company’s core offerings are distinguished by their adherence to stringent regulatory standards and advanced manufacturing processes. Over the years, Tianjin Pharmaceutical Group has achieved notable milestones, solidifying its position as a trusted name in healthcare solutions.
DitchCarbon Score
How does Tianjin Pharmaceutical Group Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tianjin Pharmaceutical Group Co., Ltd.'s score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tianjin Pharmaceutical Group Co., Ltd.'s reported carbon emissions
Tianjin Pharmaceutical Group Co., Ltd., headquartered in China (CN), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address climate change at this time. It is important to note that Tianjin Pharmaceutical Group Co., Ltd. is a current subsidiary and may inherit emissions data and climate initiatives from its parent or related organizations. However, no specific sources or initiatives have been identified in the available data. As the company navigates its climate strategy, it may consider aligning with industry standards and frameworks such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP) to enhance its climate commitments and transparency in emissions reporting.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tianjin Pharmaceutical Group Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
